Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,014 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

NCT02101905

Conditions
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma, +23 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View Trial Details
Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions
Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Huntersville, North Carolina, United States
  • Research Site Franklin, Tennessee, United States
View all 13 locations
View Trial Details
Completed

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

NCT01436656

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +23 more
Locations
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 24 locations
View Trial Details

Related conditions